Oversold Conditions For MannKind (MNKD)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.
In trading on Monday, shares of MannKind Corp (NASD: MNKD) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low #$%$015 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 50.4. A bullish investor could look at MNKD’s 29.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of MNKD shares:
MannKind Corp 1 Year Performance Chart
Looking at the chart above, MNKD’s low point in its 52 week range is $1.82 per share, with $8.70 as the 52 week high point — that compares with a last trade of $5.03. Find out what 9 other oversold stocks you need to know about »
According to the ETF Finder at ETF Channel, MNKD makes up 1.67% of the SPDR S&P Biotech ETF (AMEX: XBI)which is trading lower by about 1.6% on the day Monday.
There are 4 sales happened and a block trade of 10k all at the same second to drop below the DMA 3.97. just a bear event. just ignore them. This will backup from Monday.
Do you have any issue with it, go and complain to yahoo ceo. This MB is used for ATRS real investors not like people like you for contributing anything.
Technicals say $5.58, likely hood of approval is about 90%, because the technical doesn't know approval is coming. I am betting big time on this. Hopefully this will be trading between 6.50 to 7.50 after the approval.
As per my understanding MNKD is working for a partnership before filing the NDA on mid OCT. For that process they may have short listed the companies
Bear raid was going on for last 3 days based on rumors, tomorrow option ending for September. Run up wil start on Monday or may be tomorrow itslef. I am thinking this will be trading $5.40 before OCT 12(before FDA). Any thoughts?
I do not think there will be any big selling today. Whatever the news Merril Reported is an old news.Some shorts already taken the advanatge during pre amrket.
As per Dr. Rodbard, this study demonstrated the non-inferiority of the new more-rapid-acting injectable human insulin versus regular human insulin and the favorable impact of the faster-acting insulin on hypoglycemia and weight gain, two key side effects of currently marketed insulins which can be difficult to manage. These findings are encouraging and suggest that we can achieve proper glycemic control with reduced hypoglycemia and weight gain through the use of a more-rapid-acting form of human insulin''. Dr. Rodbard is a practicing endocrinologist based in Rockville, Maryland, a Master of the American College of Endocrinology (MACE), a Fellow of the American College of Physicians (FACP) and past president of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
You are a lier and a loser. I have professional account with fidelity, right now its showing 2.91:1, its highly bullish. Any how this kind of reports doesn't apply to biotech. But do not say lie to the public and against your religion and you.
Somebody is trying to make it go down BIOD, if you look at the pattern, the same thing happened 3 weeks ago. What they did was last 2 days were approximately 20,000 shares sold in chunks and then another 100 shares on another 25 sell orders simultaneously. So the nervous traders started selling. And these same people I am pretty sure start buying starting from Tuesday. You will see atleast a dollar up next week.